filmov
tv
IDH Mutations in Cancer

Показать описание
Mutations in the genes encoding the cytoplasmic and mitochondrial forms of isocitrate dehydrogenase (IDH1 and IDH2, respectively; collectively referred to as IDH) are frequently detected in cancers of various origins, including cholangiocarcinoma (bile duct cancer). If you are newly diagnosed, please ask your doctor about biomarker testing to find out what genes, proteins, and other substances (called biomarkers or tumor markers) that can provide information about your cancer for personalized treatment options.
IDH Mutations in Cancer
How Do IDH Mutations Cause Tumors?
The Patient is In: Introduction to IDH-mutant cancers with Matthew Vander Heiden
Vorasidenib in IDH-Mutant Glioma | NEJM
The impact of IDH mutations in MDS & evaluating the role of IDH inhibitors
The impact of IDH mutated clones in NPM1+ AML
IDH Inhibitors for Cholangiocarcinoma
From Mutation to Treatment: Understanding IDH Inhibitors
Glioblastoma/Grade 4 Astrocytoma: Personalized Medicine & Targeted Therapy
12 - Brain Cancer: IDH gene
ICRN Webinar: 'What is IDH1 mutated cholangiocarcinoma and what else can we do for it?”
The relevance of IDH inhibitors in treating chondrosarcoma
IDH1 mutation, histology, and treatment of tissue metabolites in diffuse glioma
The impact of IDH mutations on the outcomes of patients with AML & inhibitors under investigatio...
IDH-specific vaccine for high-grade gliomas
Explore IDH Mutations
Dr. Craig Thompson
Targeting IDH mutations for the treatment of AML
Mutations in IDH
Enasidenib’s Role in IDH-Mutant Acute Myeloid Leukemia
Comprehensive and Integrative Genomic Characterization of Diffuse Lower Grade Gliomas - Daniel Brat
Implications of Rapid IDH1/IDH2 Testing for Liquid and Solid Tumors
Christian Metallo - Probing cancer metabolism using isotope tracers to identify therapeutic targets
Mutated Isocitrate Dehydrogenase Enzymes and Their Role in IDH Mutant Positive Cancers
Комментарии